|
This patient is an 84 year old, male, with the initials of (b)(6).It was reported that approximately one month post replacement procedure, the patient developed a systemic infection.The cardiac re-synchronization therapy defibrillator (crt-d) system was removed.No further patient complications have been reported as a result of this event.Additionally, it was reported the patient is alive with further injury, the manufacturer is currently investigating into this matter.No additional information is available.Reference report # 1035166-2022-00081.
|
|
The adaptor used in treatment.The device was not returned for analysis.The lead adaptors were in service for approximately 1 month before being explanted on (b)(6) 2022.The device history records were reviewed to confirm that the adaptor passed all applicable in process and final inspections.Infection is a recognized clinical event referenced in the device's labeling and/or reported in the medical literature.There was no issue reported specific to the bis/bis adaptor nor our device failed to meet its performance specifications or caused or contributed to the infection.As per ifu: infection is one of the possible complications.As with the introduction of any foreign object into the body, an infection might result.Removal of the device may be required.Intermittent or continuous loss of pacing and sensing may be caused by the device's poor connection, or disconnection, or damage.Based on the investigation, a capa is not required.The event will be re-evaluated if additional information becomes available.No further follow-up is required.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|